Carson Wealth (CWM LLC)’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29K | Sell |
39,937
-9,856
| -20% | -$7.16K | ﹤0.01% | 3666 |
|
|
2025
Q1 | $40K | Buy |
49,793
+24,468
| +97% | +$19.7K | ﹤0.01% | 3154 |
|
|
2024
Q4 | $35K | Buy |
25,325
+4,043
| +19% | +$5.59K | ﹤0.01% | 3047 |
|
|
2024
Q3 | $22K | Buy |
21,282
+17,059
| +404% | +$17.6K | ﹤0.01% | 3287 |
|
|
2024
Q2 | $7K | Buy |
4,223
+4,211
| +35,092% | +$6.98K | ﹤0.01% | 3701 |
|
|
2024
Q1 | $0 | Buy |
+12
| New | – | ﹤0.01% | 4347 |
|
|
2023
Q4 | – | Sell |
-234
| Closed | -$1K | – | 4163 |
|
|
2023
Q3 | $1K | Buy |
234
+203
| +655% | +$868 | ﹤0.01% | 3939 |
|
|
2023
Q2 | $0 | Sell |
31
-372
| -92% | – | ﹤0.01% | 4185 |
|
|
2023
Q1 | $3K | Sell |
403
-63
| -14% | -$469 | ﹤0.01% | 3467 |
|
|
2022
Q4 | $4K | Sell |
466
-857
| -65% | -$7.36K | ﹤0.01% | 3269 |
|
|
2022
Q3 | $13K | Buy |
1,323
+142
| +12% | +$1.4K | ﹤0.01% | 2501 |
|
|
2022
Q2 | $9K | Buy |
1,181
+190
| +19% | +$1.45K | ﹤0.01% | 2617 |
|
|
2022
Q1 | $13K | Buy |
+991
| New | +$13K | ﹤0.01% | 2316 |
|